In the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity-preserved study (28), the use of HF medications (including β-blockers, loop diuretics, aldosterone antagonists, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and digoxin) varied between different geographic regions. The gene discussed is ACE; the disease is heart failure.